Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. (2022). SKIN The Journal of Cutaneous Medicine, 6(2), 109-121. https://doi.org/10.25251/skin.6.2.4